Company intelligence / Profile preview

Tau Capital

New York, New York, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Tau Capital is a venture capital firm that specializes in investing in deep technology and life sciences companies. The firm focuses on identifying disruptive innovations in sectors such as synthetic biology, advanced diagnostics, and healthcare infrastructure. By providing strategic capital and operational support, Tau Capital aims to accelerate the commercialization of scientific breakthroughs that address complex global challenges. Its portfolio includes notable investments in high-growth biotech companies like Ginkgo Bioworks and Emerald Cloud Lab.

Industry: Investors

Beyond the preview

Go deeper on Tau Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tau Capital.

Explore the full profile